Abstract

The successful maternal tolerance of the semi-allogeneic fetus provides an apparent immunologic paradox. Indeed, deep invasion of placental trophoblast cells into maternal uterine tissue and the following growth of the fetus have to be tolerated by a pregnant woman’s immune system. Among the various possible protective mechanisms that may be involved in human pregnancy, the expression of a non-classical pattern of human leukocyte antigen (HLA) class I molecules and the complete lack of expression of HLA class II molecules in placental tissues seem to be the most relevant mechanisms of fetal escape from maternal immune recognition. The importance of HLA molecules in fetal toleration by the maternal immune system is highlighted by pregnancy complications occurring in cases of abnormal HLA molecule expression at the maternal–fetal interface. In this review, we summarize evidences about the role of placental HLA molecules in normal and pathological pregnancies.

Highlights

  • The successful maternal tolerance of the semi-allogeneic fetus provides an apparent immunologic paradox

  • In this full literature review, we describe the physiologic modification of Human Leukocyte Antigen (HLA) molecule profiles in the human placenta required for a successful normal pregnancy

  • In the early stage of implantation, the blastocyst is surrounded by trophectoderm that will develop into both the definitive villous placenta, constituted by cytotrophoblast (CT) and syncytiotrophoblast cells (ST), as well as the invading extravillous trophoblast cells (EVT) that invade into the uterus to tap into the maternal blood supply

Read more

Summary

Introduction

The successful maternal tolerance of the semi-allogeneic fetus provides an apparent immunologic paradox. To avoid immunological recognition and rejection of fetal-derived tissues by the maternal immune system, three main mechanisms of immune escape occur in human pregnancy: (a) anatomical separation between mother and fetus tissues through the placenta; (b) modification of Human Leukocyte Antigen (HLA) molecule expression in the placenta; (c) suppression of maternal cell-mediated immunity. In this full literature review, we describe the physiologic modification of HLA molecule profiles in the human placenta required for a successful normal pregnancy. We discuss the potential pathogenic role of abnormal placental expression of HLA molecules in the occurrence of obstetrical complications

Methods
Anatomy of Maternal–Fetal Interface
Other Mechanism of Modulation of Maternal Cell-Mediated Immunity
Abnormal Expression of Placental HLA Molecules in Obstetric Syndromes
Miscarriage
Pre-Eclampsia
Preterm Delivery
Others
Findings
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.